
You can purchase shares of ALPS Medical Breakthroughs ETF (ARCA:SBIO) through any online brokerage.
There are no as such competitors for ALPS Medical Breakthroughs ETF.
There is no analysis for ALPS Medical Breakthroughs ETF to provide a consensus price target.
The stock price for ALPS Medical Breakthroughs ETF (ARCA: SBIO) is $ last updated .
There are no upcoming dividends for ALPS Medical Breakthroughs ETF.
ALPS Medical Breakthroughs ETF does not have any upcoming earnings scheduled.
There is no upcoming split for ALPS Medical Breakthroughs ETF.
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Small Cap Growth |
| Fund Inception | Dec 30, 2014 |
| Managers | Kyle Kleckner Ryan Mischke |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
| Symbol | Name | Share % |
|---|---|---|
| CGON | Cg Oncology Inc | 3.78% |
| XENE | Xenon Pharmaceuticals ... | 3.35% |
| DNTH | Dianthus Therapeutics ... | 3.43% |
| ORKA | Oruka Therapeutics Inc... | 3.30% |
| TVTX | Travere Therapeutics I... | 3.64% |
| EWTX | Edgewise Therapeutics ... | 2.83% |
| ACAD | Acadia Pharmaceuticals... | 2.82% |
| CA | Definium Therapeutics,... | 2.51% |
| MANE | Veradermics Inc | 2.45% |
| RLAY | Relay Therapeutics Inc | 2.43% |
Benzinga Rankings give you vital metrics on any stock – anytime.